These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15767358)

  • 1. Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte viability.
    Kristal AR; King IB; Albanes D; Pollak MN; Stanzyk FZ; Santella RM; Hoque A
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):727-30. PubMed ID: 15767358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
    Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
    Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of vitamins A, C, and E, carotenoids, lipids, and testosterone in whole blood stored at 4 degrees C for 6 and 24 hours before separation of serum and plasma.
    Key T; Oakes S; Davey G; Moore J; Edmond LM; McLoone UJ; Thurnham DI
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):811-4. PubMed ID: 8896892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples.
    Hartog H; van der Graaf WT; Wesseling J; van der Veer E; Boezen HM
    Clin Biochem; 2008 May; 41(7-8):636-9. PubMed ID: 18294961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
    Hernáandez J; Syed S; Weiss G; Fernandes G; von Merveldt D; Troyer DA; Basler JW; Thompson IM
    J Urol; 2005 Aug; 174(2):519-22. PubMed ID: 16006884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
    Kim J; Sun P; Lam YW; Troncoso P; Sabichi AL; Babaian RJ; Pisters LL; Pettaway CA; Wood CG; Lippman SM; McDonnell TJ; Lieberman R; Logothetis C; Ho SM
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1697-702. PubMed ID: 16030104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.
    Venkateswaran V; Fleshner NE; Klotz LH
    Prostate Cancer Prostatic Dis; 2004; 7(1):54-6. PubMed ID: 14745439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
    Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
    Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between circadian gene variants and serum levels of sex steroids and insulin-like growth factor-I.
    Chu LW; Zhu Y; Yu K; Zheng T; Chokkalingam AP; Stanczyk FZ; Gao YT; Hsing AW
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3268-73. PubMed ID: 18990770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of sex hormone-binding globulin concentrations in a cross-sectional study of healthy men randomly selected.
    Gomez JM; Maravall FJ; Gomez N; Navarro MA; Soler J
    J Nutr Health Aging; 2007; 11(1):60-4. PubMed ID: 17315082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Dunn BK; Richmond ES; Minasian LM; Ryan AM; Ford LG
    Nutr Cancer; 2010; 62(7):896-918. PubMed ID: 20924966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants block prostate cancer in lady transgenic mice.
    Venkateswaran V; Fleshner NE; Sugar LM; Klotz LH
    Cancer Res; 2004 Aug; 64(16):5891-6. PubMed ID: 15313934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
    Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
    Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on prostate cancer chemoprevention.
    Lowe JF; Frazee LA
    Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
    Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
    Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.